Circulating microRNAs as novel prognosis biomarkers for head and neck squamous cell carcinoma

References

• Polanska H, Raudenska M, Gumulec J, Sztalmachova M, Adam V, Kizek R, Masarik M. Clinical significance of head and neck squamous cell cancer biomarkers. Oral Oncol 2014; 50:168-77; PMID:24382422; http://dx.doi.org/10.1016/j.oraloncology.2013.12.008
   PubMed Web of Science ®Google Scholar
• Carthew RW, Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs. Cell 2009; 136:642-55; PMID:19239886; http://dx.doi.org/10.1016/j.cell.2009.01.035
   PubMed Web of Science ®Google Scholar
• Di Leva G, Croce CM. miRNA profiling of cancer. Curr Opin Genet Dev 2013; 23:3-11; PMID:23465882; http://dx.doi.org/10.1016/j.gde.2013.01.004
   PubMed Web of Science ®Google Scholar
• Kosaka N, Iguchi H, Ochiya T. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci 2010; 101:2087-92; PMID:20624164; http://dx.doi.org/10.1111/j.1349-7006.2010.01650.x
   PubMed Web of Science ®Google Scholar
• Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, Calin GA. MicroRNAs in body fluids–the mix of hormones and biomarkers. Nat Rev Clin Oncol 2011; 8:467-77; PMID:21647195; http://dx.doi.org/10.1038/nrclinonc.2011.76
   PubMed Web of Science ®Google Scholar
• Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008; 105:10513-8; PMID:18663219; http://dx.doi.org/10.1073/pnas.0804549105
   PubMed Web of Science ®Google Scholar
• Zen K, Zhang CY. Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers. Med Res Rev 2012; 32:326-48; PMID:22383180; http://dx.doi.org/10.1002/med.20215
   PubMed Web of Science ®Google Scholar
• Liu M, Wu H, Liu T, Li Y, Wang F, Wan H, Li X, Tang H. Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma. Cell Res 2009; 19:828-37; PMID:19546886; http://dx.doi.org/10.1038/cr.2009.72
   PubMed Web of Science ®Google Scholar
• Reis S, Pontes-Junior J, Antunes A, Dall'Oglio M, Dip N, Passerotti C, Rossini G, Morais D, Nesrallah A, Piantino C, et al. miR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancer. BMC Urol 2012; 12:14; PMID:22642976; http://dx.doi.org/10.1186/1471-2490-12-14
   PubMed Web of Science ®Google Scholar
• Hsu CM, Lin PM, Wang YM, Chen ZJ, Lin SF, Yang MY. Circulating miRNA is a novel marker for head and neck squamous cell carcinoma. Tumour Biol 2012; 33:1933-42; PMID:22811001; http://dx.doi.org/10.1007/s13277-012-0454-8
   PubMed Web of Science ®Google Scholar
• Maclellan SA, Lawson J, Baik J, Guillaud M, Poh CF, Garnis C. Differential expression of miRNAs in the serum of patients with high-risk oral lesions. Cancer Med 2012; 1:268-74; PMID:23342275; http://dx.doi.org/10.1002/cam4.17
   PubMed Web of Science ®Google Scholar
• Stamatopoulos B, Meuleman N, Haibe-Kains B, Saussoy P, Van Den Neste E, Michaux L, Heimann P, Martiat P, Bron D, Lagneaux L. microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification. Blood 2009; 113:5237-45; PMID:19144983; http://dx.doi.org/10.1182/blood-2008-11-189407
   PubMed Web of Science ®Google Scholar
• Li J, Guo Y, Liang X, Sun M, Wang G, De W, Wu W. MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4. J Cancer Res Clin Oncol 2012; 138:763-74; PMID:22270966; http://dx.doi.org/10.1007/s00432-012-1154-x
   PubMed Web of Science ®Google Scholar
• Hui AB, Lenarduzzi M, Krushel T, Waldron L, Pintilie M, Shi W, Perez-Ordonez B, Jurisica I, O'Sullivan B, Waldron J, et al. Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Clin Cancer Res 2010; 16:1129-39; PMID:20145181; http://dx.doi.org/10.1158/1078-0432.CCR-09-2166
   PubMed Web of Science ®Google Scholar
• Laios A, O'Toole S, Flavin R, Martin C, Kelly L, Ring M, Finn SP, Barrett C, Loda M, Gleeson N, et al. Potential role of miR-9 and miR-223 in recurrent ovarian cancer. Mol Cancer 2008; 7:35; PMID:18442408; http://dx.doi.org/10.1186/1476-4598-7-35
   PubMed Web of Science ®Google Scholar
• Chen Z, Jin Y, Yu D, Wang A, Mahjabeen I, Wang C, Liu X, Zhou X. Down-regulation of the microRNA-99 family members in head and neck squamous cell carcinoma. Oral Oncol 2012; 48:686-91; PMID:22425712; http://dx.doi.org/10.1016/j.oraloncology.2012.02.020
   PubMed Web of Science ®Google Scholar
• Sun D, Lee YS, Malhotra A, Kim HK, Matecic M, Evans C, Jensen RV, Moskaluk CA, Dutta A. miR-99 family of MicroRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation. Cancer Res 2011; 71:1313-24; PMID:21212412; http://dx.doi.org/10.1158/0008-5472.CAN-10-1031
   PubMed Web of Science ®Google Scholar
• Kuo YZ, Tai YH, Lo HI, Chen YL, Cheng HC, Fang WY, Lin SH, Yang CL, Tsai ST, Wu LW. MiR-99a exerts anti-metastasis through inhibiting myotubularin-related protein 3 expression in oral cancer. Oral Dis 2014; 20:e65-75; PMID:23731011; http://dx.doi.org/10.1111/odi.12133
   PubMed Web of Science ®Google Scholar
• Doghman M, El Wakil A, Cardinaud B, Thomas E, Wang J, Zhao W, Peralta-Del Valle MH, Figueiredo BC, Zambetti GP, Lalli E. Regulation of insulin-like growth factor-mammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors. Cancer Res 2010; 70:4666-75; PMID:20484036; http://dx.doi.org/10.1158/0008-5472.CAN-09-3970
   PubMed Web of Science ®Google Scholar
• Nagaraja AK, Creighton CJ, Yu Z, Zhu H, Gunaratne PH, Reid JG, Olokpa E, Itamochi H, Ueno NT, Hawkins SM, et al. A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer. Mol Endocrinol 2010; 24:447-63; PMID:20081105; http://dx.doi.org/10.1210/me.2009-0295
   PubMed Web of Science ®Google Scholar
• Li J-H, Liu S, Zhou H, Qu L-H, Yang J-H. starBase v2. 0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res 2014; 42:D92-7; PMID:24297251; http://dx.doi.org/10.1093/nar/gkt1248
   PubMed Web of Science ®Google Scholar
• Yen YC, Shiah SG, Chu HC, Hsu YM, Hsiao JR, Chang JY, Hung WC, Liao CT, Cheng AJ, Lu YC, et al. Reciprocal regulation of microRNA-99a and insulin-like growth factor I receptor signaling in oral squamous cell carcinoma cells. Mol Cancer 2014; 13:6; PMID:24410957; http://dx.doi.org/10.1186/1476-4598-13-6
   PubMed Web of Science ®Google Scholar